Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

AXDX
Accelerate Diagnostics, Inc.
stock NASDAQ

Inactive
May 14, 2025
0.0340USD-61.364%(-0.0540)67,483,332
Pre-market
0.00USD-100.000%(-0.09)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 13, 2022
11:48AM EST  Accelerate Diagnostics Sees Prelim. Q4 Sales $3.3M vs $3.92M Est., FY21 Sales $11.8M vs $12.28M Est.   Benzinga
09:17AM EST  Accelerate Diagnostics Expects Q4 Total Revenue To Be About $3.3 Mln Vs. $3.1 Mln Prior Year   RTTNews
09:15AM EST  Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021   PR Newswire
Jan 12, 2022
09:16AM EST  Accelerate Diagnostics Wins Suzhou Innovation Award to Support Continued China   PR Newswire
Dec 29, 2021
09:30AM EST  Accelerate Diagnostics to Participate Virtually in 40th Annual J. P. Morgan   PR Newswire
Nov 24, 2021
03:42PM EST  Accelerate Diagnostics Form 4 Shows Co. Director, 10% Owner Jack Schuler Bought ~49K Co. Shares   Benzinga
Nov 22, 2021
07:40AM EST  Accelerate Diagnostics Inc. (AXDX) announced the publication of its Improving Outcomes and Antibiotic Stewardship Study in the journal Clinical Infectious Diseases.   RTTNews
07:26AM EST  Accelerate Publishes Improving Outcomes &Antibiotic Stewardship Study In Journal Clinical Infectious Diseases   RTTNews
07:01AM EST  New Accelerate Pheno(r) System Multi-Center Study Published in Clinical   PR Newswire
Nov 9, 2021
05:49PM EST  Accelerate Diagnostics Q3 EPS $(0.15) Beats $(0.33) Estimate, Sales $3.12M Miss $3.91M Estimate   Benzinga
04:06PM EST  Accelerate Diagnostics Reports Third Quarter 2021 Financial Results   PR Newswire
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
Oct 19, 2021
08:01AM EDT  Accelerate Diagnostics Schedules Call to Review 3rd Quarter 2021 Results   PR Newswire
Sep 28, 2021
08:18AM EDT  The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive   Benzinga
08:16AM EDT  The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments   Benzinga
05:10AM EDT  Accelerate Diagnostics Director Jack Schuler Reported Purchase of 27,353 Shares @ Avg Price of $5.50/Share in Form 4 Filing on Monday   Benzinga
Sep 23, 2021
09:15AM EDT  Million in Principal Amount of Its 2.50% Convertible Senior Notes due 2023 for Common Stock   PR Newswire
Aug 31, 2021
11:37AM EDT  Return on Capital Employed Overview: Accelerate Diagnostics   Benzinga
Aug 20, 2021
07:45AM EDT  The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 5, 2021
05:48PM EDT  Accelerate Diagnostics Q2 EPS $(0.36) Misses $(0.33) Estimate, Sales $2.80M Miss $3.07M Estimate   Benzinga
04:06PM EDT  Accelerate Diagnostics Reports Second Quarter 2021 Financial Results   PR Newswire
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Aug 3, 2021
11:10AM EDT  Accelerate Diagnostics Granted U.S. Patent Titled 'Lens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing'   Benzinga
08:12AM EDT  Accelerate Diagnostics Gets CE Mark For Fast Antimicrobial Susceptibility Test For Use With Existing ID Systems   RTTNews
08:06AM EDT  Accelerate Diagnostics Reports CE Mark, Availability In Europe Of Fast Antimicrobial Susceptibility Test For Use With Existing ID Systems   Benzinga
08:02AM EDT  Accelerate Diagnostics Announces CE Mark and Availability in Europe of Fast   PR Newswire
Jul 16, 2021
07:37AM EDT  The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study   Benzinga
Jul 15, 2021
08:06AM EDT  Accelerate Diagnostics Schedules Call to Review 2nd Quarter 2021 Results   PR Newswire
Jul 7, 2021
08:01AM EDT  Accelerate Diagnostics Launches a Fast Antimicrobial Susceptibility Test for   PR Newswire
Jun 30, 2021
10:08AM EDT  Accelerate Diagnostics Says Will Have 3 Data Presentations At European Congress Of Clinical Microbiology & Infectious Diseases   Benzinga
10:06AM EDT  New Accelerate Pheno(r) Landmark Study Validates Important Clinical Benefits to   PR Newswire
Jun 2, 2021
12:48PM EDT  Accelerate Diagnostics Receives Notice Of Allowance For U.S. Patent Titled 'INSTRUMENT AND SYSTEM FOR RAPID MICROORGANISM IDENTIFICATION AND ANTIMICROBIAL AGENT SUSCEPTIBILITY TESTING'   Benzinga
May 19, 2021
08:02AM EDT  Accelerate Diagnostics to Participate in William Blair 41st Annual Growth Stock   PR Newswire
May 14, 2021
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 6, 2021
05:23PM EDT  Accelerate Diagnostics Q1 EPS $(0.41) Down From $(0.39) YoY, Sales $2.52M Up From $2.34M YoY   Benzinga
04:06PM EDT  Accelerate Diagnostics Reports First Quarter 2021 Financial Results   PR Newswire
May 5, 2021
02:35PM EDT  Accelerate Diagnostics to Host Call to Review First Quarter 2021 Results   PR Newswire
Feb 24, 2021
10:00AM EST  Accelerate Diagnostics shares were trading lower after the company reported worse-than-expected Q4 EPS and sales results.   Benzinga
Feb 23, 2021
04:36PM EST  Accelerate Diagnostics Q4 EPS $(0.33) Misses $(0.32) Estimate, Sales $3.10M Miss $4.12M Estimate   Benzinga
04:16PM EST  Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2020 Financial   PR Newswire
04:09AM EST  Earnings Scheduled For February 23, 2021   Benzinga
Feb 1, 2021
08:02AM EST  Accelerate Diagnostics schedules call to review 2020 fourth quarter and full   PR Newswire
08:01AM EST  Science & Diagnostic Tools Conference on February 18, 2020, at 4:00 p.m. Eastern Time   PR Newswire
Jan 27, 2021
04:03PM EST  - Accelerate Diagnostics Inc Files For Mixed Shelf Of Up To $150M   Benzinga
Jan 12, 2021
06:10AM EST  Accelerate Diagnostics Sees Prelim. Q4 Sales $3.1M vs $4.41M Est., Sees Prelim. FY20 Sales $11.2M vs $12.43M Est.   Benzinga
06:07AM EST  Accelerate Diagnostics Sees Q4 Total Revenue To Be About $3.1 Mln   RTTNews
06:01AM EST  Accelerate Diagnostics Announces Preliminary Fourth Quarter and Full-Year 2020   PR Newswire
Nov 5, 2020
05:01PM EST  Accelerate Diagnostics Q3 EPS $(0.33), Inline, Sales $3.60M Beat $3.27M Estimate   Benzinga
04:29PM EST  Accelerate Diagnostics Reports Third Quarter 2020 Financial Results   PR Newswire
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Oct 12, 2020
09:06AM EDT  Accelerate Diagnostics Announces Virtual Product Demo Day and Schedules Call to   PR Newswire
Oct 8, 2020
10:00AM EDT  Benzinga's Top Upgrades, Downgrades For October 8, 2020   Benzinga
05:45AM EDT  BTIG Initiates Coverage On Accelerate Diagnostics with Neutral Rating   Benzinga
Sep 16, 2020
09:05AM EDT  Accelerate Diagnostics Announces New FDA Clearance For Accelerate PhenoTest Improvements   Benzinga
09:04AM EDT  Accelerate Diagnostics Announces FDA Clearance For Accelerate PhenoTest Improvements   RTTNews
09:03AM EDT  Accelerate Diagnostics Announces New FDA Clearance for Accelerate PhenoTest(r)   PR Newswire
Sep 10, 2020
09:16AM EDT  Accelerate Diagnostics Reports FDA Emergency Use Authorization For COVID-19 Individual IgM And IgG Antibody Tests   RTTNews
09:03AM EDT  Accelerate Diagnostics Announces FDA Emergency Use Authorization For COVID-19 Individual IgM and IgG Antibody Tests   Benzinga
09:03AM EDT  Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19   PR Newswire
Aug 24, 2020
09:15AM EDT  Accelerate Diagnostics Names Nedal Safwat Chief Strategy Officer   PR Newswire
Aug 19, 2020
10:40AM EDT  Accelerate Diagnostics shares are trading higher after the company announced on Tuesday the FDA issued Emergency Use Authorization for its BioCheck Covid-19 antibody testing system. UPDATE: Shares have since reversed, now lower.   Benzinga
Aug 18, 2020
04:21PM EDT  Accelerate Diagnostics Press Release Highlights FDA Emergency Use Authorization For BioCheck COVID-19 Antibody Testing System; NOTE: Emergency Use Authorization Was Disclosed In FDA Letter Dated Aug. 17   Benzinga
04:15PM EDT  Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19   PR Newswire
11:53AM EDT  CORRECTION: Earlier Headline On Accelerate Diagnostics Partner BioCheck Incorrectly Tagged Ticker 'ACRX'   Benzinga
11:53AM EDT  Letter To Accelerate Diagnostics Partner BioCheck From Aug. 17 Shows FDA Emergency Use Authorization For BioCheck SARS-CoV-2 IgG and IgM Combo Test   Benzinga
Aug 10, 2020
10:25AM EDT  Piper Sandler Maintains Overweight on Accelerate Diagnostics, Raises Price Target to $18   Benzinga
Aug 6, 2020
05:36PM EDT  Accelerate Diagnostics Q2 EPS $(0.35) Misses $(0.34) Estimate, Sales $2.13M Miss $2.46M Estimate   Benzinga
04:16PM EDT  Accelerate Diagnostics Reports Second Quarter 2020 Financial Results &   PR Newswire
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
Jul 16, 2020
08:01AM EDT  Accelerate Diagnostics Schedules Call to Review Second Quarter 2020 Results   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC